Exhibit 99.1 "As we completed our first full year as a public company, I'm encouraged by the strong execution and outstanding results our team continued to deliver, with momentum once again across all segments, service offerings and regions," said President and CEO Jennifer Scanlon. "Strong organic growth, improved profitability and increased cash flow generation reflect our strategic focus on high-growth markets and ongoing operational excellence. Our global laboratory additions and expansions directly add ...